1. Changes in urine volume and serum albumin in incident hemodialysis patients
- Author
-
Melissa Soohoo, Anna T. Mathew, Elani Streja, Taehee Kim, Kamyar Kalantar-Zadeh, Jason A. Chou, Rieko Eriguchi, Yoshitsugu Obi, Csaba P. Kovesdy, Connie M. Rhee, and Amanda R. Tortorici
- Subjects
Urinary volume ,medicine.medical_specialty ,Urine volume ,biology ,business.industry ,medicine.medical_treatment ,030232 urology & nephrology ,Urology ,Serum albumin ,Albumin ,Renal function ,Hematology ,030204 cardiovascular system & hematology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Nephrology ,Internal medicine ,Diabetes mellitus ,medicine ,biology.protein ,Hemodialysis ,Hypoalbuminemia ,business - Abstract
Introduction Hypoalbuminemia is a predictor of poor outcomes in dialysis patients. Among hemodialysis patients, there has not been prior study of whether residual kidney function or decline over time impacts serum albumin levels. We hypothesized that a decline in residual kidney function is associated with an increase in serum albumin levels among incident hemodialysis patients. Methods In a large national cohort of 38,504 patients who initiated hemodialysis during 1/2007-12/2011, we examined the association of residual kidney function, ascertained by urine volume and renal urea clearance, with changes in serum albumin over five years across strata of baseline residual kidney function, race, and diabetes using case-mix adjusted linear mixed effects models. Findings Serum albumin levels increased over time. At baseline, patients with greater urine volume had higher serum albumin levels: 3.44 ± 0.48, 3.50 ± 0.46, 3.57 ± 0.44, 3.59 ± 0.45, and 3.65 ± 0.46 g/dL for urine volume groups of
- Published
- 2016